perjeta
Showing 1 - 5 of 5
Breast Cancer Trial in Saint Petersburg (BCD-178, Perjeta)
Active, not recruiting
- Breast Cancer
- BCD-178
- Perjeta
-
Saint Petersburg, Russian Federation
- +1 more
Feb 13, 2023
Similarity of Pharmacokinetics and Safety Trial (HS627(210mg/7ml), HS627(420mg/14ml), Perjeta)
Not yet recruiting
- Similarity of Pharmacokinetics and Safety
- HS627(210mg/7ml)
- +2 more
- (no location specified)
Apr 5, 2022
Breast Cancer Trial in Worldwide (Perjeta, Herceptin, Docetaxel)
Active, not recruiting
- Breast Cancer
- Perjeta
- +5 more
-
Bruxelles, Belgium
- +55 more
Jan 18, 2023
Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Ikeja (Paclitaxel, Perjeta, Herceptin SC)
Withdrawn
- Breast Cancer
- +2 more
- Paclitaxel
- +7 more
-
Ikeja, Lagos State, NigeriaLagos State University College of Medicine
Apr 18, 2019